PPARG and abscess: Indeed,recent studies by our laboratory have revealed that the PPAR-γ agonist ciglitazone demonstratesbeneficial effects with delayed administration in an experimental brain abscessmodel as revealed by accelerated abscess encapsulation and reduction inbacterial burdens [71].